2 assets in Myxofibrosarcoma
Therapeutic assets addressing Myxofibrosarcoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
okn4395 Myxofibrosarcoma | Epkin | P1 | CC (43) |
Pembrolizumab Myxofibrosarcoma | Epkin | P1 | CC (43) |